Logo image of YCBD

CBDMD INC (YCBD) Stock Price, Forecast & Analysis

USA - NYSE Arca - NYSEARCA:YCBD - US12482W4087 - Common Stock

1.35 USD
-0.01 (-0.74%)
Last: 12/31/2025, 8:04:00 PM
1.37 USD
+0.02 (+1.48%)
After Hours: 12/31/2025, 8:04:00 PM

YCBD Key Statistics, Chart & Performance

Key Statistics
Market Cap12.03M
Revenue(TTM)N/A
Net Income(TTM)-4.85M
Shares8.91M
Float7.03M
52 Week High6.54
52 Week Low0.47
Yearly Dividend0
Dividend Yield0%
EPS(TTM)-4.04
PEN/A
Fwd PEN/A
Earnings (Next)02-11 2026-02-11
IPO2017-11-17
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


YCBD short term performance overview.The bars show the price performance of YCBD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 50 100

YCBD long term performance overview.The bars show the price performance of YCBD in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of YCBD is 1.35 USD. In the past month the price increased by 126.89%. In the past year, price decreased by -70.78%.

CBDMD INC / YCBD Daily stock chart

YCBD Latest News, Press Relases and Analysis

YCBD Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 48.87 1.02T
JNJ JOHNSON & JOHNSON 19.94 498.60B
MRK MERCK & CO. INC. 11.95 261.26B
PFE PFIZER INC 7.78 141.57B
BMY BRISTOL-MYERS SQUIBB CO 8.22 109.81B
ZTS ZOETIS INC 19.85 55.45B
RPRX ROYALTY PHARMA PLC- CL A 9.4 22.30B
VTRS VIATRIS INC 5.34 14.34B
ELAN ELANCO ANIMAL HEALTH INC 23.57 11.24B
AXSM AXSOME THERAPEUTICS INC N/A 9.21B
BLTE BELITE BIO INC - ADR N/A 5.58B
CRNX CRINETICS PHARMACEUTICALS IN N/A 4.42B

About YCBD

Company Profile

YCBD logo image cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. The company is headquartered in Charlotte, North Carolina and currently employs 42 full-time employees. The company went IPO on 2017-11-17. The firm has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The firm's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.

Company Info

CBDMD INC

8845 Red Oak Blvd

Charlotte NORTH CAROLINA 28217 US

CEO: Martin A. Sumichrast

Employees: 42

YCBD Company Website

YCBD Investor Relations

Phone: 17044453060

CBDMD INC / YCBD FAQ

What does CBDMD INC do?

cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. The company is headquartered in Charlotte, North Carolina and currently employs 42 full-time employees. The company went IPO on 2017-11-17. The firm has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The firm's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.


What is the stock price of CBDMD INC today?

The current stock price of YCBD is 1.35 USD. The price decreased by -0.74% in the last trading session.


Does CBDMD INC pay dividends?

YCBD does not pay a dividend.


What is the ChartMill rating of CBDMD INC stock?

YCBD has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


What do analysts say about CBDMD INC (YCBD) stock?

7 analysts have analysed YCBD and the average price target is 2.04 USD. This implies a price increase of 51.11% is expected in the next year compared to the current price of 1.35.


Can you provide the ownership details for YCBD stock?

You can find the ownership structure of CBDMD INC (YCBD) on the Ownership tab.


What is the outstanding short interest for CBDMD INC?

The outstanding short interest for CBDMD INC (YCBD) is 56.48% of its float.


YCBD Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to YCBD. When comparing the yearly performance of all stocks, YCBD is a bad performer in the overall market: 86.67% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

YCBD Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to YCBD. The financial health of YCBD is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

YCBD Financial Highlights

Over the last trailing twelve months YCBD reported a non-GAAP Earnings per Share(EPS) of -4.04. The EPS increased by 70.81% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -49.02%
ROE -79.38%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%92.13%
Sales Q2Q%3.59%
EPS 1Y (TTM)70.81%
Revenue 1Y (TTM)N/A

YCBD Forecast & Estimates

7 analysts have analysed YCBD and the average price target is 2.04 USD. This implies a price increase of 51.11% is expected in the next year compared to the current price of 1.35.

For the next year, analysts expect an EPS growth of 94.95% and a revenue growth 4.95% for YCBD


Analysts
Analysts82.86
Price Target2.04 (51.11%)
EPS Next Y94.95%
Revenue Next Year4.95%

YCBD Ownership

Ownership
Inst Owners4.89%
Ins Owners1.71%
Short Float %56.48%
Short Ratio0.3